 |
|
|
|
|
Product Details:
Payment & Shipping Terms:
|
| Name: | Niraparib | Cas: | 1038915-60-4 |
|---|---|---|---|
| Mf: | C25H32F3N3O4 | Purity: | 99% |
| Appearance: | White Powder | Package: | 1kg/bag Or 25kgs/drum |
| High Light: | Anti Cancer Niraparib Tosylate Monohydrate,1038915-60-4 Pharmaceutical Ingredients,Niraparib Tosylate Monohydrate |
||
New Anti-Cancer Niraparib Tosylate Monohydrate Powder API 99% CAS 1038915-60-4 Mk-4827 Powder
|
Product Name |
New Anti-Cancer Niraparib Tosylate Monohydrate Powder CAS 1038915-60-4 |
| CAS | 1038915-60-4 |
| Appearance | White to off- White crystallinity powder |
| Molecular formula | C25H32F3N3O4 |
| Molecular Weight | 320.39 |
| Assay | 98% |
| Shelf Life | 24 months when properly stored |
| Storage | Keep in a cool, dry, dark location |
| What is Niraparib?
Niraparib is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian cancer. |
Niraparib is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian cancer..
The drug is approved by the US FDA for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy.
| Product Name | CAS No. | Product Name | CAS No. |
| Lufenuron | 103055-07-8 | Toltrazuril | 69004-03-1 |
| Nitenpyram | 120738-89-8 | Praziquantel/Biltricide | 55268-74-1 |
| Fenbendazole | 43210-67-9 | Tetramisole Hcl | 5086-74-8 |
| Levamisole | 14769-73-4 | Ponazuril | 9004-4-2 |
| Diclazuril | 101831-37-2 | Florfenicol | 73231-34-2 |
| Ivermectin | 70288-86-7 | Enrofloxacin Hcl | 112732-17-9 |
| Albendazole | 54965-21-8 | Mebendazole | 31431-39-7 |
Contact Person: July
Tel: 25838890
